Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Darius M. Moshfeghi, MD
Paola Dorta S., MD, MHA, and Andrés Kychenthal B., MD
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Recent Supplements
3 Years After Pegcetacoplan Approval: Addressing Post-Injection Complications and Understanding EZ:RPE Loss as a Potential Measure of Clinical Response
Content Sponsored by Apellis, A subsidiary of Biogen
View Supplement
Business Matters: Leveraging Data in the Retina Practice
Editorially independent content supported with advertising by Eyepoint
One to Watch: Alexis Warren, MD
Editorially independent supported by Abbvie and Regenxbio
View Insert
Defining Early Geographic Atrophy Requires More Than Lesion Size
Editorially Independent Content, Supported With Advertising From Astellas
Rising Stars: Jonathan Lin, MD, PhD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
This activity is supported by an independent educational grant from AlconVision, LLCĀ
View Program
This program will open on EvolveMedEd.com.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE